New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Century Therapeutics, Inc.

Contributing Author

Recent Articles by Century Therapeutics, Inc.

Mar-12	Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates IPSC -8.42% GlobeNewswire
Feb-25	Century Therapeutics to Participate in Upcoming Investor Conferences in March IPSC GlobeNewswire
Jan-08	Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes IPSC +36.15% GlobeNewswire
Dec-09	Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors IPSC GlobeNewswire
Nov-25	Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference IPSC GlobeNewswire
Nov-13	Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update IPSC -17.54% GlobeNewswire
Nov-13	Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes IPSC -17.54% GlobeNewswire
Oct-14	Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference IPSC GlobeNewswire
Aug-22	Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference IPSC GlobeNewswire
Aug-14	Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update IPSC GlobeNewswire
May-28	Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress IPSC GlobeNewswire
May-15	Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update IPSC +8.23% IPSC +5.79% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)